Nocturia in Parkinson's Disease: Why Does It Occur and How to Manage?

被引:31
作者
Batla, Amit [1 ]
Phe, Veronique [2 ,3 ,4 ]
De Min, Lorenzo [2 ,3 ]
Panicker, Jalesh N. [2 ,3 ]
机构
[1] UCL Inst Neurol, Dept Motor Neurosci & Movement Disorders, 7 Queen Sq, London WC1N 3BG, England
[2] Natl Hosp Neurol & Neurosurg, Dept Uroneurol, London, England
[3] UCL Inst Neurol, London, England
[4] Univ Paris 06, Pitie Salpetriere Acad Hosp, AP HP, Pierre & Marie Curie Med Sch,Dept Urol, Paris, France
来源
MOVEMENT DISORDERS CLINICAL PRACTICE | 2016年 / 3卷 / 05期
关键词
nocturia; Parkinson's disease; uro-neurology;
D O I
10.1002/mdc3.12374
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundNocturia is one of the commonest nonmotor symptoms in Parkinson's disease (PD) and has a significant impact on quality of life both for patients and their carers. There exists a relation between nocturia and poor sleep quality, falls, and institutionalization. Nocturia may manifest as a result of reduced functional bladder capacity or nocturnal polyuria; however, most often the cause is multifactorial. Disorders of circadian rhythm regulation are known to occur with sleep disturbances in PD may also contribute to nocturia. Methods and ResultsIn this review, an overview of the assessment and management of nocturia in patients with PD is presented. History taking, medication review, and a bladder diary form the cornerstone of the evaluation. Urinalysis, ultrasonography, and urodynamic studies help to assess the cause for lower urinary tract symptoms and exclude concomitant pathologies, such as bladder outlet obstruction. Antimuscarinic medications are the first-line treatment for the overactive bladder; however, caution is needed when using these medications in individuals predisposed to cognitive impairment. Desmopressin is effective for managing nocturnal polyuria. ConclusionsAn individualized approach is recommended to optimize the management of nocturia in PD.
引用
收藏
页码:443 / 451
页数:9
相关论文
共 101 条
  • [1] Nocturnal Polyuria and Nocturnal Arginine Vasopressin (AVP): A Key Factor in the Pathophysiology of Monosymptomatic Nocturnal Enuresis
    AbdelFatah, Diaa
    Shaker, Hassan
    Ismail, Mahmoud
    Ezzat, Mahmoud
    [J]. NEUROUROLOGY AND URODYNAMICS, 2009, 28 (06) : 506 - 509
  • [2] The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society
    Abrams, P
    Cardozo, L
    Fall, M
    Griffiths, D
    Rosier, P
    Ulmsten, U
    van Kerrebroeck, P
    Victor, A
    Wein, A
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 187 (01) : 116 - 126
  • [3] Sleep issues in Parkinson's disease
    Adler, CH
    Thorpy, MJ
    [J]. NEUROLOGY, 2005, 64 (12) : S12 - S20
  • [4] ANDERSEN J T, 1985, International Urology and Nephrology, V17, P35, DOI 10.1007/BF02089401
  • [5] [Anonymous], 2009, PLEAS MIND GAPPARKIN
  • [6] EFFECTS OF APOMORPHINE AND L-DOPA ON THE PARKINSONIAN BLADDER
    ARANDA, B
    CRAMER, P
    [J]. NEUROUROLOGY AND URODYNAMICS, 1993, 12 (03) : 203 - 209
  • [7] Mineralocorticoid Receptor Activation Contributes to the Supine Hypertension of Autonomic Failure
    Arnold, Amy C.
    Okamoto, Luis E.
    Gamboa, Alfredo
    Black, Bonnie K.
    Raj, Satish R.
    Elijovich, Fernando
    Robertson, David
    Shibao, Cyndya A.
    Biaggioni, Italo
    [J]. HYPERTENSION, 2016, 67 (02) : 424 - 429
  • [8] Hip tractures, nocturia, and nocturnal polyuria in the elderly
    Asplund, R.
    [J]. ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2006, 43 (03) : 319 - 326
  • [9] Asplund R, 2002, NETH J MED, V60, P276
  • [10] Falls in outpatients with Parkinson's disease - Frequency, impact and identifying factors
    Balash, Y
    Peretz, C
    Leibovich, G
    Herman, T
    Hausdorff, JM
    Giladi, N
    [J]. JOURNAL OF NEUROLOGY, 2005, 252 (11) : 1310 - 1315